Nigrostriatal catecholamine metabolism in guinea pigs is altered by purine enzyme inhibition

Experimental Brain Research

Volumn 127, Issue 2, 1999, Pages 147-150

  Church, William H ^a   Rappolt, Gabrielle ^a  

^a TRINITY COLLEGE   (United States)

Author keywords

Allantoxanimide; Allopurinot; Catecholamine metabolism; Catecholamines; Dopamine; Norepinephrine; Oxidation; Parkinson's disease; Striatum; Substantia nigra; Uric acid

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; ALLANTOXANAMIDE; ALLOPURINOL; ASCORBIC ACID; DOPAMINE; NORADRENALIN; URATE OXIDASE; URIC ACID; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ARTICLE; CATECHOLAMINE METABOLISM; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME INHIBITION; GUINEA PIG; NONHUMAN; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

3,4-DIHYDROXYPHENYLACETIC ACID; ALLOPURINOL; ANIMALS; CATECHOLAMINES; CORPUS STRIATUM; DOPAMINE; ENZYME INHIBITORS; GUINEA PIGS; INJECTIONS; MALE; NOREPINEPHRINE; OXONIC ACID; SUBSTANTIA NIGRA; URIC ACID;

EID: 0033037455     PISSN: 00144819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002210050784     Document Type: Article

References (27)

1. Burkhardt CR, Weber HK (1994) Parkinson's disease: a chronic, low-grade antioxidant deficiency? Med Hypoth 43:111-114
2. Chiueh CC (1994) Auto-oxidation of dopamine and formation of free radicals in vivo. In: Louilot A, Durkin T, Spampinato U, Cador M (eds) Monitoring molecules in neuroscience. Universities of Bordeaux I and II, pp 127-128
3. Chiueh CC, Miyake H, Peng M (1993) Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism. Adv Neurol 60:251-258
4. Church WH, Ward VL (1994) Uric acid is reduced in the substantia nigra in Parkinson's disease: effect on dopamine oxidation. Brain Res Bull 33:419-425
5. 3: a microdialysis study in the substantia nigra of the guinea pig. Mol Chem Neuropath 27:131-144
6. Desole MS, Esposito G, Migheli R, Fresu L, Sircana S, Miele M, De Natale G, Miele E (1995a) Allopurinol protects against manganese-induced oxidative stress in the striatum and in the brainstem of the rat. Neurosci Lett 192:73-76
7. Desole MS, Miele M, Esposito G, Fresu LG, Migheli R, Sangani D, Sircana S, Grella G, Miele E (1995b) Neuronal antioxidant system and MPTP-induced oxidative stress in the striatum and brain stem of the rat. Pharmacol Biochem Behav 51:581-592
8. Desole MS, Esposito G, Fresu L, Migheli R, Sircana S, Delogu R, Miele D, Miele E (1996) Further investigation of allopurinol effects on MPTP-induced oxidative stress in the striatum and brain stem of the rat. Pharmacol Biochem Behav 54:377-383
9. Enrico P, Esposito G, Mura MA, Fresu L, De Natale G, Miele E, Desole MS, Miele M (1997) Effect of morphine on striatal dopamine metabolism and ascorbic acid and uric acid release in freely moving rats. Brain Res 745:173-182
10. Ferré S, Fuxe K, von Euler G, Johansson B, Fredholm BB (1992) Adenosine-dopamine interactions in the brain. Neuroscience 51:501-512
11. Ferré S, Fredholm BB, Morelli M, Popoli P, Fuxe K (1997) Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci 20: 482-487
12. Good PF, Olanow CW, Perl DP (1992) Neuromelanin-containing neurons of the substantial nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study. Brain Res 593: 343-346
13. Götz ME, Künig G, Riederer P, Youdim MBH (1994) Oxidative stress: free radical production in neuronal degeneration. Pharmacol Ther 63:37-122
14. Hooper DC, Spitsin S, Kean RB, Champion JM, Dickson GM, Chaudhry I, Koprowski H (1998) Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci U S A 95: 675-680
15. Iwahashi H, Morishita H, Ishii T, Sugata R, Kido R (1989) Enhancement by catechols of hydroxyl-radical formation in the presence of ferric ions and hydrogen peroxide. J Biochem 105: 429-434
16. Jenner P (1991) Oxidative stress as a cause of Parkinson's disease. Acta Neurol Scand 136:6-15
17. Ko KM, Godin DV (1990) Inhibition of transition metal ion-catalysed ascorbate oxidation and lipid peroxidation by allopurinol and oxypurinol. Biochem Pharmacol 40:803-809
18. LeWitt PA, Galloway M, Matson W, Milbury P, McDermott M, Oakes D, Shoulson I (1992) CSF studies in unmedicated Parkinson's disease: dopamine metabolism and xanthine. Soc Neuroci Abstr 18:1248
19. Loeffler DA, LeWitt PA, DeMaggio AJ, Milbury PE, Matson WR, Juneau PL (1998) Altered guanosine and guanine concentrations in rabbit striatum following increased dopamine turnover. Brain Res Bull 45:297-299
20. Marangos PJ, Boulenger JP (1985) Basic and clinical aspects of adenosinergic neuromodulalion. Neurosci Biobehav Rev 9: 421-430
21. Miele M, Espisito G, Migheli R, Sircana S, Zangani D, Fresu GL, Desole MS (1995) Effects of allopurinol on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurochemical changes in the striatum and in the brainstem of the rat. Neurosci Lett 183:155-159
22. Mueller K (1990) The effects of haloperidol and amphetamine on ascorbic acid and uric acid in caudate and nucleus accumbens of rats as measured by voltammetry in vivo. Life Sci 47: 735-742
23. Okada M, Mizuno K, Kaneko S (1996) Adenosine A1 and A2 re-ceptors modulate extracellular dopamine levels in rat striatum. Neurosci Lett 212:53-56
24. Schapira AH (1996) Neurotoxicity and the mechanisms of cell death in Parkinson's disease. Adv Neur 69:161-165
25. Sevanian A, Davies KJA, Hochstein P (1991) Serum urate as an antioxidant for ascorbic acid, Am J Clin Nutr 54:1129S-1134S
26. Tan S, Radi R, Gaudier F, Evans RA, Rivera A, Kirk KA, Parks DA (1993) Physiologic levels of uric acid inhibit xanthine oxidase in human plasma. Pediatr Res 34:303-307
27. Ward VL, McGinty JF, Church WH (1993) Iron(III) chloride injection increases nigral uric acid in guinea pig. Neuroreport 4:787-790